Pages that link to "Item:Q2919476"
From MaRDI portal
The following pages link to Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables (Q2919476):
Displaying 10 items.
- Sample size determination in clinical trials with multiple endpoints (Q2516980) (← links)
- Assessing additional benefit in noninferiority trials (Q2792768) (← links)
- Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables (Q2919476) (← links)
- Sample size determination and re‐estimation for matched pair designs with multiple binary endpoints (Q4921958) (← links)
- Sample Size Requirements and Study Duration for Testing Main Effects and Interactions in Completely Randomized Factorial Designs When Time to Event is the Outcome (Q5249188) (← links)
- A simple procedure to estimate the optimal sample size in case of conjunctive coprimary endpoints (Q5280177) (← links)
- Letter to the Editor (Q5410276) (← links)
- Power analysis for cluster randomized trials with multiple binary co‐primary endpoints (Q6047743) (← links)
- Sample size estimation using a latent variable model for mixed outcome co-primary, multiple primary and composite endpoints (Q6628372) (← links)
- Power analyses for stepped wedge designs with multivariate continuous outcomes (Q6629948) (← links)
